CO-1686 5mg

CO-1686 is a novel, oral, targeted covalent (irreversible) inhibitor of the cancer-causing mutant forms of epidermal growth factor receptor (EGFR) currently being studied for the treatment of non-small cell lung cancer (NSCLC).

Price Not Available 5mg CO-1686 5mg Supplier Page

Trivial name	CO-1686 5mg
Catalog Number	A13028-5
Alternative Name(s)	N-(3-((2-((4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide
Molecular Formula	C27H28F3N7O3
CAS#	1374640-70-6
SMILES	CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC
Size	5mg
Supplier Page	http://www.adooq.com/co-1686.html